208 Chapter 6 Supplemental table 5. Continued Sleep wake transition disorders Estimated effect 95% CI Lower bound Upper bound Intervention - Placebo - Hydrocortisone -0.93 -3.33 1.48 Start group - Placebo - Hydrocortisone 0.47 -0.41 1.35 Week of maintenance treatment -0.05 -0.10 -0.01 Interaction intervention and week of maintenance treatment - Placebo - Hydrocortisone 0.02 -0.03 0.08 Sex -0.02 -0.90 0.86 Asparaginase -1.18 -2.85 0.50 Age at registration -0.07 -0.19 0.06 Parent who completed questionnaire -0.10 -0.91 0.72 Disorders of excessive somnolence Estimated effect 95% CI Lower bound Upper bound Intervention - Placebo - Hydrocortisone -1.23 -4.38 1.93 Start group - Placebo - Hydrocortisone 1.41 0.09 2.73 Week of maintenance treatment -0.06 -0.12 0.0005 Interaction intervention and week of maintenance treatment - Placebo - Hydrocortisone 0.03 -0.04 0.11 Sex 0.36 -0.97 1.69 Asparaginase -1.85 -4.34 0.65 Age at registration -0.13 -0.32 0.06 Parent who completed questionnaire -0.78 -1.95 0.38
RkJQdWJsaXNoZXIy MTk4NDMw